Dogs in Hospitals: What Studies Show for Patients, Staff and the Dogs
Michael Sauerwein
Therapy dogs now visit pediatric wards, emergency departments, intensive care units and psychiatric units in many countries, and some hospitals have facility dogs that work regularly alongside nurses or child life specialists. Short-term reductions in anxiety and distress are the most consistent finding, while effects on pain, depression and physiology are less consistent: a review of pediatric hospital studies found that only two of five controlled pain studies showed a significant improvement, and a dog-only review across health care reported that most outcome measures showed no significant effect (Correale et al., 2022; Lundqvist et al., 2017). Few trials have tested whether the dog adds anything beyond a friendly visitor, and where they did, results were mixed (Gee et al., 2024, 2026).
This article reviews what systematic reviews and individual trials show for children and adults in acute care, for psychiatric inpatients and for hospital staff. It examines the hygiene and infection data for visiting dogs, including licking, treats, hand hygiene and raw feeding, what little is known about the welfare of the dogs, and the methodological reasons why the evidence remains weak, and closes with practical consequences and research gaps.
1. Why Dogs in Hospitals?
1.1 Settings and Terms
Dogs enter hospitals in several roles. Many programs rely on volunteer visiting teams, a dog with its handler, who come for scheduled rounds on pediatric, oncology, rehabilitation or psychiatric wards, in emergency departments and, increasingly, in intensive care. Some hospitals employ facility dogs, which live with a staff member, often a nurse or child life specialist, and work with that person during regular shifts (Jensen et al., 2021; Murata-Kobayashi et al., 2023). Assistance dogs trained for one person with a disability are a separate field with different rules (what studies show for assistance dogs and their handlers).
Animal-assisted activities (AAA) usually mean less structured visits, animal-assisted therapy (AAT) a goal-directed intervention within a treatment plan, and animal-assisted interventions (AAI) the umbrella term. An umbrella review of 15 systematic reviews found that all of them complained about the poor quality of AAI studies and that terms were used inconsistently (Santaniello et al., 2020). Here, terms are used as the original authors used them.
Dogs predominate in the studies and surveys reviewed here. A systematic review of pediatric hospital studies found that all 21 included studies used dogs (Correale et al., 2022), and in a national survey of UK intensive care units, dogs were the only animals used: 32 of 74 responding units (43.2%) offered animal-assisted interventions, 30 of them as activities only. Among the 32 programs, weekly visits (11) and visit durations of 30 to 60 minutes (14) were the most common single categories (Wright et al., 2025).
1.2 What Kind of Evidence Exists
The evidence consists of several systematic reviews, a growing number of randomized trials, mostly with fewer than 100 participants, and many uncontrolled before-and-after, survey and qualitative studies, mainly from the United States, Canada, Italy and Spain. In the pediatric review, 15 of 21 studies examined a single dog visit; among the 16 studies reporting session duration, visits lasted 6 to 60 minutes, with a mean of 16.4 minutes (Correale et al., 2022). Outcomes were usually measured immediately before and after a visit, mostly with self-report scales, sometimes with cortisol, heart rate or blood pressure.
A methodological review attributed the mixed results of human-animal interaction research to varied methods, intermittent use of standardized measures and manualized protocols, variability in both human and animal participants and an unquantified "dosage", and asked whether effects are "due specifically to the animal's presence or to other aspects of the intervention such as novelty, attention, or human interaction" (Rodriguez et al., 2021). That question runs through every section below.
2. What the Reviews Say
2.1 Children in Hospital: Less Distress, Pain Only Sometimes
Correale et al. (2022) searched four databases to April 2020 and included 21 studies of children and adolescents admitted to or visiting hospital, without a meta-analysis. Anxiety and behavioral distress decreased in most studies. For pain, uncontrolled designs showed significant before-and-after reductions, but "when the study design involved a control group, only two of the five studies showed a significant improvement". Risk-of-bias ratings showed "some concerns" for randomization in 87.5% and for outcome measurement in 75% of the randomized trials, and confounding bias in all non-randomized studies. The authors concluded that "further, more rigorous studies are still needed". The first author was supported by a grant from the Italian Kennel Club.
Zhang et al. (2021) pooled seven studies of animal-assisted therapy on pain in children, all with dogs: four RCTs and three studies classed as controlled clinical trials. The pooled estimate was reported as −0.53 (95% CI −0.77 to −0.30), labeled a mean difference, although the subgroup estimates were standardized mean differences across different pain scales; it is best read as a standardized effect of about half a standard deviation. All three studies classed as "controlled" trials were single-group before-and-after studies without an independent control group, according to the review's methods table, so that subgroup is not a controlled comparison. In the study table, one RCT found that the "pain score did not decrease". The authors concluded that AAT "can relieve pain in children to some extent" but called for more high-quality studies. The two pediatric reviews overlap: both include the two trials with significant pain results, one of them the post-surgical trial described below (Calcaterra et al., 2015), so their agreement is not independent replication.
2.2 Dog-Only Reviews Across Health Care
Lundqvist et al. (2017) restricted their review to dogs and to quantitative studies with at least 20 participants and a control group in health care, nursing homes or home care. Of 18 studies of at least moderate quality, three showed no effect and 15 at least one significant positive effect, "but in most studied outcome measures there was no significant treatment effect". The strongest potential appeared for dog-assisted therapy in psychiatric conditions, and dog-assisted support "may have positive effects on stress and mood" during medical procedures. No study examined cost-effectiveness.
A 2026 review of randomized trials of dog-assisted interventions for mental health and neurodevelopmental conditions included 33 papers on 29 RCTs, 11 of them in hospitals and 10 in care facilities; only five were rated high quality overall (Shoesmith et al., 2026). Positive effects were reported by 57% of studies for social skills or behavior, 50% for symptom severity, 43% for depression and 33% for agitation. Mean adherence to CONSORT reporting standards was 48.6%, and intervention materials were described in only 18.2%. Control conditions ranged from usual care and waiting lists to relaxation, reminiscence and a discussion group about animals, which prevented a meta-analysis. Because many trials involved older people with dementia, the authors warned that findings on depression and agitation "are not generalisable to populations of younger individuals". Both dog-only reviews include nursing homes, and their trial sets partly overlap with each other and with the elderly-care literature (what studies show for dogs in elderly care and dementia).
2.3 Intensive Care and Psychiatry: Too Few Studies
For intensive care, a review restricted to controlled studies found only six, all with dogs, with 118 cases and 128 controls; results varied widely and "no one has used increased survival or zoonotic risk as outcomes" (Fiore et al., 2023). The authors concluded: "The evidence on the effectiveness of AAIs in ICU settings is scarce and no data are available on their safety. AAIs use in the ICU must be considered experimental".
For inpatient child and adolescent psychiatry, a German-led review identified five studies of canine-assisted therapy, most with quality deficits (Fornefeld et al., 2025). They reported positive effects on psychopathology, relationships and well-being, and four described more interaction and communication and less withdrawal and aggression. The authors' verdict: "A cautiously positive perspective is warranted, but a general recommendation for CAT cannot be given."
2.4 A Mixed-Species Review on Benefits and Risks
Bert et al. (2016) reviewed 36 publications on animal-assisted interventions in hospital settings; eleven focused primarily on risks and safety issues, including recommendations and reports rather than clinical effectiveness studies. "Most studies used dogs, but other animals were effectively employed", so this review describes animal-assisted interventions in general rather than visiting dogs. Allergies, infections including MRSA and animal-related accidents were identified as major risks. Hygiene protocols were recommended to reduce risk; however, the review did not directly establish that these precautions reliably prevent clinical infections. Animal welfare data were missing in most studies, and only a few studies were RCTs. The authors concluded that AAA and AAT "seem useful and safe for a wide range of diseases. However, many aspects remained unclear". The safety verdict rests on studies that mostly did not measure harms systematically: a 2020 review of hospital AAI risks found that no study up to that point had systematically measured risks other than infections, "such as phobias, allergies, or injuries" (Dalton, Waite, et al., 2020); later studies such as Cook et al. (2025) documented selected adverse events.
2.5 Why the Reviews Disagree
Counting studies with at least one significant result looks more favorable than pooling: 15 of 18 controlled studies found some positive effect, yet most outcome measures showed none (Lundqvist et al., 2017). Pooling uncontrolled before-and-after studies with controlled trials can inflate estimates, as the "controlled" subgroup in Zhang et al. (2021) shows, and the reviews share trials, so similar conclusions partly rest on the same small studies.
3. Children
3.1 Oncology: No Clear Effect for the Child in Controlled Trials
The most rigorous pediatric oncology trial in this review randomized inpatients at Seattle Children's Hospital to volunteer dog visits or usual care, with computer-generated blocks and concealed allocation (Chubak et al., 2024). It planned 40 participants but recruited 26 (12 dog, 14 control) before it was stopped because of slow recruitment and COVID-19. Children's immediately reported symptom burden (PedsQL Present Functioning VAS: anxiety, sadness, anger, worry, fatigue and pain) did not differ significantly between groups (adjusted difference −3.0 points; 95% CI −12.4 to 6.4). This scale assesses current symptoms, not overall quality of life, and the wide confidence interval leaves room for benefits or harms. Parents in the dog group reported lower state anxiety after the first visit (adjusted difference −13.7, −21.4 to −6.0), but they had also reported higher anxiety at baseline, which complicates the comparison. Outcome staff were not blinded, and the attention of a visit was not controlled. The authors did not detect a difference in the primary patient outcome and emphasized that low recruitment limited statistical power. The hygiene results of this trial are discussed in Section 7.
Uncontrolled studies look more positive. In a Brazilian quasi-experimental study, 24 children in outpatient oncology treatment at the Barretos Cancer Hospital (mean age 8.58 in the Results section; the abstract instead reports 8.0) took part in three 30-minute open-group sessions with two dogs (Silva & Osório, 2018). Pain, irritation and stress decreased from before to after the program (pain p = .046, stress p = .005), and caregivers reported less anxiety, mental confusion and tension; depressive symptoms did not change significantly. The authors named "the absence of a control group" and a small sample that "was not statistically estimated" as limitations. The study was funded by the hospital's own foundation.
At Essen University Hospital in Germany, 60 pediatric oncology inpatients (median age 10.3) received 100 visits over four years from a single dog, a male Labrador Retriever and former search-and-rescue dog aged 7 to 11 during the study, handled by a volunteer physician and a paramedic (Steff et al., 2024). Weekly sessions lasted 25 to 45 minutes, and children chose anything from passive to active contact and could leave the room at any time. Acceptance of being in the hospital increased (median 7.25 versus 4.50), and median state stress was 1.00 one hour after versus 4.25 one hour before the visit (both P < 0.001). The design was uncontrolled and non-randomized, only a face scale and unstructured interviews were used, and the interviews "were conducted by the dog handler", which the authors acknowledged as a potential source of bias. The hygiene protocol of this program is described in Section 7.
3.2 Surgery and Procedures
In a randomized, open-label pilot in Pavia, Italy, 40 children aged 3 to 17 had a dog present for 20 minutes during post-operative awakening or received standard care without a dog (Calcaterra et al., 2015). The primary endpoint, EEG beta activity after the dog entered, was recorded in 20 of 20 children in the dog group and in none of the 14 control children with evaluable EEG recordings; a complete EEG recording was unavailable for six other control children. The heart rate profile also differed between groups. Anesthesia duration differed between groups at baseline and was accounted for in the statistical models. Salivary cortisol did not differ (interaction p = .70). Faces pain scores were lower in the dog group at the second time point (p = .01; no pain in 18 of 20 versus 9 of 20 children), but analgesic use did not differ. No adverse outcomes occurred. Outcomes were measured "by a researcher unblinded to the patient's group", and there was no attention control.
At a pediatric hematology-oncology clinic in New York, 285 children aged 5 to 17 undergoing needlestick procedures were compared depending on whether the hospital's facility dog was scheduled to be present at the time of their appointment: the dog attended morning sessions in even-numbered months and afternoon sessions in odd-numbered months (Spikestein et al., 2024). All children received support from a certified child life specialist; 143 also had the facility dog. Patient-reported pain was lower with the dog (odds ratio 0.62, 95% CI 0.39 to 0.97), but patient anxiety (OR 0.75, 0.47 to 1.19) and caregiver ratings did not differ significantly. A single needlestick attempt sufficed in 94.4% versus 88.0%. Allocation was not randomized, some outcomes were rated by the clinician who knew the group, and the study was funded by the hospital's own child life department.
Before outpatient echocardiography at a US children's hospital, 70 children aged 18 months to 8 years met a facility dog; anxiety rated by a trained nurse observer was lower after the procedure than before (p < .001), and 97.2% of caregivers and 87.9% of staff found the intervention helpful (Grissim et al., 2025). The authors noted that a control group "was not included", so the decrease cannot be separated from the end of the procedure itself. In addition, the dog handler was a certified child life specialist who prepared children with a picture book and other coping strategies; the dog's independent contribution cannot be isolated.
3.3 Emergency Department and Intensive Care
The clearest pediatric emergency trial randomized 80 children (mean age 10.9) at Riley Children's Hospital in Indianapolis (Kelker et al., 2025). Both groups received child life specialist care, and the intervention group additionally spent about ten minutes with a therapy dog and its handler. This controls for child life support but not for a novel visitor. Child-reported anxiety (0–10 faces scale) fell by 2.7 points with the dog and by 1.5 points without it (P = .02), and parent-rated anxiety by 3.2 versus 1.8 points (P = .008); a drop of more than 2.5 points occurred in 46% versus 23%. At the later measurement (T2), planned for about 120 minutes but actually taken on average after 150 minutes in the dog group and 133 minutes in the control group, the between-group difference in anxiety was not statistically significant (P = .70). For T2, the paper reports 3.0 points in the dog group versus 3.6 in controls in the main text, but 3.3 versus 3.5 in Table 2; these values are inconsistent. Nor does a nonsignificant difference establish that any possible effect had disappeared completely. In the additional repeated-measures analysis, the group-by-time interaction was not statistically significant for child reports (P = .11) or parent reports (P = .12); this qualifies the short-term between-group findings. Use of sedatives or anxiolytics was 18% versus 35%, a difference that was not statistically significant (P = .08), and salivary cortisol fell in both groups without a between-group difference. No adverse events occurred. The authors acknowledged that "Blinding to the presence of a dog was not possible; therefore, this could be a source of bias and overestimation of effects." Children who feared dogs or had dog allergy or dog-triggered asthma were excluded. The trial was funded by the Human Animal Bond Research Institute (HABRI).
In pediatric intensive care, cardiovascular intensive care and hematology-oncology units at Phoenix Children's Hospital, individual children were randomly assigned to a dog group (44 children) or a wait-list control group (36 children): the dog group received a 5- to 10-minute visit, while control patients continued their current activity during measurement and received a visit later (Jennings et al., 2021). In addition, 94 study days were scheduled at random. Of 5,963 children screened over four years, 80 aged 2 to 19 were analyzed. Caregiver-rated activity three hours after the visit was higher in the dog group, and observer-rated mood improved more. The study found "no significant group differences for cortisol reactivity"; a difference appeared only in the recovery pattern. Research assistants could not be blinded, and staff interruptions and family presence were not controlled. Funders included PetSmart Charities, and one co-author founded the company that supplied cortisol assays.
In an uncontrolled program organized by a Madrid pediatric intensive care unit, 61 children older than three participated in 74 sessions, including 13 sessions held in other hospital services (López-Fernández et al., 2024). The authors reported no relevant adverse events; median anxiety scores fell from 38 to 23 and fear scores from 1 to 0 (both p < .01), and the project received an overall rating of 9.69 out of 10. The original paper itself reports inconsistent survey counts: 164 in the abstract and 167 in the results section. Baseline pain was low, and the anxiety scale had not been validated for intensive care.
3.4 Advanced Illness and End of Life
In interviews with nine children aged 5 to 17 with relapsed or refractory cancer and twelve parents, after roughly weekly 15-minute sessions with a trained dog and handler for up to 12 weeks, 20 of 21 described positive aspects, and "The only negative aspect reported was too little time with the dog" (Cowfer et al., 2021). In the first Japanese hospital with full-time facility dogs, staff rated the dogs' impact highest in end-of-life care and in gaining children's cooperation for procedures (Murata-Kobayashi et al., 2023). Both are perceptions, not measured outcomes; the interview study was funded by HABRI.
In practice: On pediatric wards, teams trained at our school let the child decide the level of contact, from watching the dog from the bed to brushing it, and agree with parents and nurses beforehand which children the dog may approach. Visits stay short, the handler explains what the dog likes, and the dog never lies on the bed without a clean barrier and the ward's permission. This is a practice recommendation, not a study result.
4. Adults
4.1 Emergency Department: Anxiety, Pain and the Handler Question
At Eskenazi Hospital in Indianapolis, adults judged by a physician to have at least moderate anxiety were enrolled in pairs on the same shift, and one patient of each pair was randomly assigned to 15 minutes with a certified therapy dog and its handler, the other to usual care (Kline et al., 2019). Of 93 willing patients, seven had an aversion to dogs, and 40 per group took part; 81% were women. Median anxiety fell from 6 to 2 with the dog and stayed at 6 in controls after 30 minutes (P < .001), and remained lower at 90 minutes. Pain medication was given to 1 of 40 versus 7 of 40 patients, a difference that was not statistically significant (P = .056). The authors called the trial "primarily hypothesis-generating" and noted that the effect could stem "from human companionship, given that the handlers had some degree of conversation with all patients". Controls knew they would not see a dog, which may have caused disappointment.
At the Royal University Hospital emergency department in Saskatoon, Canada, days rather than patients were randomized: on dog days, 97 patients received a 10-minute visit by a therapy dog team plus usual care, on control days 101 received usual care (Carey et al., 2022). Pain on a 0–10 scale fell by an average of 0.9 points in the dog group only, and anxiety, depression and well-being also improved only in the dog group; blood pressure and heart rate did not change. A reduction of less than one point on an 11-point scale is small for the individual patient. Intervention participants had to be willing to see a dog, whereas controls were not asked. The published analysis describes an individual-level ANOVA without reporting an adjustment for possible dependence among patients recruited on the same randomized day, leaving the statistical uncertainty of the group comparisons harder to assess. The trial was also registered only after data collection, so the prespecification of analyses cannot be verified against a prospective registration. The authors stated that "the study did not specifically account separately for the impact of the handlers and therapy dogs" and recommended "the addition of an attention control".
In the same emergency department, 80% of 100 surveyed adult patients who had not received a dog visit said they personally would want one. Asked separately why other patients might want a visit, 92% suggested reduced anxiety, 87% reduced frustration, 90% increased comfort and 59% pain relief; these were perceptions rather than measured treatment effects (Reddekopp et al., 2020). Older adults and women more often named cultural background or tradition as a possible reason against a visit, a reminder that not every patient welcomes a dog.
4.2 Wards and Surgery
In a Boston RCT, 72 patients after hip or knee replacement were assigned to a 15-minute visit by one certified therapy dog 30 minutes before each of three physical therapy sessions, or to standard care (Harper et al., 2015). Pain scores after physical therapy were lower in the dog group at each session (for example 5.2 ± 1.5 versus 7.1 ± 1.3 after the first; all p < .001), but the change from the first to the third session did not differ between groups (p = .10). Satisfaction with nursing communication and pain management was higher. No adverse events or surgical-site infections were recorded up to 12 months. Patients were not blinded, assessor blinding was not stated, analgesic dosing was not controlled, and the single dog's handler was an orthopedic surgery resident, so dog and handler effects cannot be separated.
At Massachusetts General Hospital, 59 inpatients chose to interact with a dog, its handler or both; pain, respiratory rate and negative mood decreased and perceived energy increased from before to after the visit (Coakley & Mahoney, 2009). The authors listed "the lack of a control group, the small number of subjects and the convenience sample" as limitations.
In the long-term care department of a military hospital in Prague, 72 inpatients aged 51 to 100 were assigned by envelope to sessions with one therapist and one dog over 15 weeks plus standard care (33) or standard care alone (39) (Machová, Procházková, et al., 2019). Blood pressure, heart rate and daily functioning did not differ between groups. Only patients who showed happiness when encountering the dog and agreed to take part in dog-assisted therapy were considered suitable candidates, limiting generalizability to all long-term inpatients. Mood was reported to improve, but the reported test statistic suggests that repeated session ratings were analyzed as independent observations, and mood in the control group also changed, so this finding is uncertain.
4.3 Older Inpatients: A Handler-Only Control
A pilot RCT at an academic medical center in Richmond, Virginia, compared three conditions for 42 medical inpatients aged 59 and over: 20-minute visits on three days by a dog with its handler, by the handler alone, or usual care (Gee et al., 2024). Loneliness ratings improved more with dog-and-handler visits than with usual care, using one-tailed tests that the authors justified with a priori hypotheses; handler-only visits did not differ significantly from usual care, and a direct advantage of dog-and-handler over handler-only visits was not established. In 44 patients from the same trial, mood improved more from pre- to post-session in the dog group than under usual care (one-tailed test, p = .034), but not significantly more than with handler-only conversations. The proportion exceeding a predefined anxiety threshold decreased only in the dog group; however, changes in continuously measured anxiety did not differ significantly between groups. No significant treatment effect on depression was detected. The short-term benefits "were not sustained from day 1 to day 5 or to either follow-up" (Gee, Townsend, Friedmann, Barker, & Mueller, 2025). Both papers were funded by an unrestricted grant from Mars Petcare and the Waltham Petcare Science Institute, and several authors reported pet-industry links.
4.4 Intensive Care
Johns Hopkins clinicians described how they introduced dogs into intensive care: involve risk management and infection control, partner with credentialing organizations, write a policy covering goals, roles, logistics, accidents and evaluation, and start "with patients who have a high likelihood of success, such as patients without delirium, communicable disease, or the need for contact precautions" (Hosey et al., 2018). This program description reports no outcome data.
In a single-arm study in a tertiary intensive care unit in Canberra, Australia, 70 patients and 71 family members took part in sessions of at least 15 minutes (Cook et al., 2025). Median anxiety fell from 5 to 0 in patients and from 6 to 3 in relatives (both p < .001). No participant reported discomfort, and there were no dog bites and no dislodged tubes or drains. No new MRSA was detected within 14 days; two of 70 patients (3%) had new VRE colonization on routine screening, both after transfer from another hospital without admission screening. The authors named the "nonrandomized design" and lack of a control group as limitations, and outcomes were self-rated immediately after the session.
In the UK survey, infection prevention concerns were the most common barrier among units without a program (26 of 34, 76.5%), followed by lack of funding and understaffing, and only 20.6% cited a lack of evidence (Wright et al., 2025). "No site reported any episode of patient harm during an animal visit; one site reported an episode of animal harm (consumption of prohibited food item)." The response rate was 30.6%, and all data were self-reported.
4.5 Palliative Care: A German Example
At the University Centre for Palliative Medicine in Düsseldorf, two certified dog-assisted therapy teams documented 84 sessions with 52 patients over one year; only 18 patients had more than one session, because of discharge or death, and relatives took part in 19 sessions (Schmitz et al., 2017). A qualitative analysis of the handlers' protocols identified closeness and trust, calm and relaxation, self-efficacy, distraction and the dog as a catalyst for communication. The authors cautioned that "the findings are based on the perceptions of the handlers and are not necessarily based on what actually occurred".
5. Psychiatric Wards
5.1 Adults: Depression Also Fell with a Human Visitor
The three-arm design of the older-inpatient trial was repeated with 60 adults in an acute psychiatric unit: dog and handler, handler-only conversation, or usual care, 20 minutes a day for three days (Gee, Townsend, Friedmann, Barker, Thakre, et al., 2025; Gee et al., 2026). For loneliness, the UCLA short-form measure showed a larger reduction with dog visits both immediately after sessions and across the three intervention days; on the additional single-item analog scale, however, loneliness declined most over the three days in the handler-only conversation group. From baseline to day 5, there was no significant overall difference between groups; a subgroup advantage of dog visits emerged only among participants living with a dog at home. Mood and anxiety improved immediately after individual dog visits, but these advantages were not consistently detectable over longer measurement periods. Across the three intervention days, mood improved more in the handler-only conversation group than in the dog-visit group. Depression scores fell by day 5 to a similar extent with dog-and-handler and handler-only visits, with both comparing favorably with usual care. Patterns by sex and dog ownership depended on the measure and timepoint and should be interpreted cautiously given the small subgroup sizes. With 16 dog-and-handler teams and too few returns at one and six months, effects of individual dogs and durability could not be assessed. The authors wrote: "To our knowledge, there is no way to conduct AAI research in a double-blind manner". Funding came from HABRI, and several authors reported support from pet-industry companies. The two papers report different outcomes of the same 60 patients and count as one trial.
Recruitment alone took 23 months: of 264 referred patients, 72 were enrolled, and 12 had to be replaced because they completed no intervention day (Townsend et al., 2026). In a Toronto mental health and addiction hospital, focus groups with 38 inpatients held with a therapy dog present showed that the dog "increased the motivation to participate" in research (Sikstrom et al., 2020); this study reports no clinical outcomes.
5.2 Children and Adolescents
A non-randomized study on acute child and adolescent psychiatry wards in three Spanish hospitals initially enrolled 190 adolescents; 178 were analyzed (114 with a dog and 64 without) after four of 118 in the dog group and eight of 72 in the control group dropped out (Rodrigo-Claverol et al., 2026). Both groups received two one-hour sessions over two consecutive weeks using the same group program, with a dog added in the intervention arm. For general self-efficacy, the between-group difference in change was two points on a 10–40 scale (p = 0.036; effect size r = 0.158); its clinical importance is uncertain. State anxiety decreased significantly within the dog group but not compared with controls (p = 0.294). The control group came from only one hospital and was assessed after the dog group; the trial was registered retrospectively. Unequal dropout also complicates interpretation.
In a Barcelona child psychiatric day hospital, 23 children under 13 had fewer emotional and behavioral outbursts and better attendance on dog days, and therapist ratings improved, but parent ratings did not change (Guillen Guzmán et al., 2022). Conventional therapy continued throughout and there was no control group, so the dog's contribution cannot be isolated.
5.3 Long-Stay Schizophrenia
In a Spanish psychiatric care center, institutionalized patients with chronic schizophrenia were randomized to twice-weekly one-hour AAT sessions replacing one other rehabilitation activity, or to the usual program, for six months; 22 completed the study (14 versus 8) (Calvo et al., 2016). Both groups improved in positive and overall symptoms, only the AAT group improved in negative symptoms, adherence was higher with AAT, and patients' salivary cortisol decreased. These improvements refer to within-group comparisons; neither final PANSS scores nor changes in PANSS differed significantly between the AAT and control groups. "One patient withdrew from the study due to the risk of harm to the therapy dogs", there was no intention-to-treat analysis, and the authors stated that the results "cannot be relied upon as general evidence of efficacy". The study was funded by a foundation linked to the pet-food industry.
6. Hospital Staff
6.1 Short Dog Contacts During a Shift
One observed hospital program illustrates how extensively staff members also participate in dog visits. At an academic medical center in Virginia, 1,016 interactions were observed after a therapy dog program restarted. Healthcare workers accounted for 71.69% of visit recipients, whereas 57.2% of the recorded interactions involved healthcare workers alone. Mean contact duration was 1.56 minutes for staff, 2.58 minutes for adult patients and 5.81 minutes for pediatric patients (Townsend et al., 2022).
A review of twelve studies involving healthcare workers included, according to its results table, four randomized studies (two with crossover designs), four before-and-after studies, and one each with a quasi-experimental, mixed-methods, cross-sectional, and qualitative design. Programs were often received positively, but these heterogeneous designs do not establish a consistent causal effect. Criticism of prescheduled visit times should not be taken as the view of all healthcare workers (Acquadro Maran et al., 2022). In a Czech within-subject study, 20 nurses worked through three conditions in randomized order: work without a break, a break of their choice, or a break with a dog; cortisol decreased after the dog break only in the nine nurses from internal medicine and long-term care, not in the whole sample (Machová, Součková, et al., 2019). At a US Veterans Affairs clinic, 20 approximately hour-long sessions with therapy dogs were held over three months. On average, about half the employees working on a given day attended each session; among 15 survey respondents who reported their participation, the mean was 9 of the 20 sessions; mood improved immediately after dog contacts from 2.9 to 4.5 on an unvalidated five-point scale. In surveys conducted before the program (22 responses) and afterwards (16 responses), mean patient-related burnout was 40.0 and 18.0, respectively (p = .002). This does not demonstrate a change in the same individuals; differences in work-related (p = .38) and personal burnout (p = .40) were not statistically significant. There was no control group (Etingen et al., 2020). Interviews with 37 healthcare workers and handlers suggested that programs were perceived to reduce staff stress and improve morale, and that leadership support was key to overcoming administrative and infection-control barriers (Dalton et al., 2022).
6.2 Facility Dogs: Benefits, Burdens and Short-Term Relief
A cross-sectional study compared 65 pediatric professionals who worked with a facility dog with 65 matched colleagues (Jensen et al., 2021). Emotional exhaustion did not differ significantly (d = 0.08), which does not establish that both groups were equally exhausted; facility-dog handlers reported higher personal accomplishment, more positive emotions, better perceived mental health and less depression, but not less anxiety. The authors noted that the "lack of randomised group assignment ... prevents results from being interpreted with any determination of causality". The study was funded by an animal-health company and the US National Institutes of Health.
In an open-ended survey, 73 handlers of 46 facility dogs across 17 US children's hospitals described less stress, better workplace relationships and morale and, in their own assessment, greater rapport and comfort for patients. They also reported added burdens and responsibilities at work (Rodriguez et al., 2022). This qualitative analysis was drawn from the same larger research project as the quantitative comparison by Jensen et al. (2021), rather than providing independent confirmation. Patients and families were not directly surveyed for these claims; the two publications had the same funders. In a Japanese hospital survey, 431 of 626 full-time staff responded; 270 who had observed or accompanied facility-dog interventions were analyzed. They rated support in end-of-life care and clinical procedures particularly favorably (Murata-Kobayashi et al., 2023). The paper reports nine selected questions from a set of twenty. The two facility dogs worked in succession, each with a nurse handler. These are staff perceptions, not patient outcomes measured directly. Staff of the first Canadian hospital with a full-time facility dog for staff support described feeling valued by the employer but also "short-term relief that may be limited to some staff roles" (Baweja et al., 2026). A phenomenological study interviewed eleven nurses who met one dog in six weekly ten-minute visits during their shifts (Kubanick & Scharfman, 2025). These are descriptions of experience, not effect estimates.
7. Hygiene and Infection Control
7.1 What Visiting Dogs Pick Up
Hygiene is the best-studied risk in hospital programs. A healthy toy poodle that visited hospitals and long-term care facilities weekly carried an epidemic human strain of C. difficile, probably acquired in the healthcare environment; "To date, no study, including this one, has shown that interspecies transmission occurs; however, that possibility exists" (Lefebvre et al., 2006).
The key cohort study followed 194 AAI dogs in Ontario and Alberta for a year, with fecal samples and nasal swabs every two months: 96 dogs that visited hospitals or long-term care facilities and 98 that worked in other settings such as schools (Lefebvre et al., 2009). C. difficile acquisition was 2.4 times higher in the healthcare-visiting dogs (incidence rate ratio 2.4, 95% CI 1.22 to 5.07). For MRSA, the incidence rate ratio was 4.7 (95% CI 0.91 to 47.10); this very wide interval includes 1. A separate univariable analysis in the same paper, however, found a statistically significant association between visiting healthcare facilities and MRSA detection (odds ratio 6.3, 95% CI 1.29 to 30.26; p = 0.02). Only nine dogs tested positive for MRSA overall, so these estimates are imprecise. Neither analysis demonstrates a causal transmission pathway to patients. Visiting groups of children was also associated with C. difficile acquisition.
In a US university program involving dogs and two cats, 17 of 118 screening tests were positive, 14 of them for potentially zoonotic organisms. The original paper reports conflicting dog counts: 22 in the abstract but 20 in the results section. Among handlers responding to the survey, 70% expressed no concerns about disease transmission, and adherence to infection control practices was inadequate (Boyle et al., 2019).
7.2 Microbes Travel Both Ways
A pilot study at Johns Hopkins swabbed patients, four therapy dogs and the environment before and after 13 group sessions in pediatric oncology and analyzed the microbiome (Dalton et al., 2021). The nasal microbiome of patients and dogs changed during visits, and more contact went with more sharing between patients and dogs and between patients. A dog-targeted antiseptic protocol (chlorhexidine shampoo approximately 24 hours beforehand and chlorhexidine wipes every five to ten minutes during the session) was used in five of 13 visits and was associated with changes in some microbiome similarity measures; results differed by diversity metric and involved, among others, rare microbial taxa. Inferred sharing was based on similarities in microbial 16S profiles, not direct demonstration of transmission of a specific pathogen. The authors concluded that "the therapy dog is both a potential source of and a vehicle for the transfer of microorganisms to patients but not necessarily the only source". The study was small, measured no health outcomes, and could not determine the direction of transfer. A narrative review from the same group pointed to "the absence of infection risk mitigation strategies targeting animals" in hospital infection control (Dalton, Rock, et al., 2020).
The Seattle trial compared dog visits with required hand sanitization for anyone touching the dog (before contact and at the end of the visit) against usual care with no study-mandated sanitization in the control group. The adjusted difference in hand microbial load was −0.04 log10 CFU/mL (95% CI −0.60 to 0.52), with the upper CI limit below the prespecified non-inferiority margin of 1.19 log10 CFU/mL (Chubak et al., 2024). Lacking a clinically validated threshold, the margin was derived from variability in baseline microbial load. The trial therefore tested the package of dog contact plus hygiene measures against usual care, not the isolated effect of the dog or of sanitization. The trial did not examine transfer to the nose, the dog or the environment and was not powered to detect differences in clinical infection rates. At least one clinical infection occurred in 4 of 12 intervention patients (33%) and 3 of 14 control patients (21%); the sample is too small to establish a reliable between-group difference. One protocol deviation was recorded "when a dog licked a patient". Two children in the intervention group died during the study; the original paper states that neither death was attributable to the intervention.
7.3 Licking, Treats and Raw Feeding
The behavior of the dog during visits matters. In the case-control part of the Ontario-Alberta cohort, dogs that licked patients were more likely to acquire MRSA (odds ratio 18.8, 95% CI 1.95 to 878.88) and C. difficile (OR 3.5, 1.18 to 10.62), and dogs that accepted treats from patients were more likely to acquire MRSA (OR 11.2, 1.21 to 527.55) (Lefebvre et al., 2009). The extremely wide intervals reflect small numbers, so the magnitude of these statistical associations is uncertain. In a separate analysis of the entire dog cohort, raw feeding was associated with detection of AmpC-producing E. coli (OR 17.2; 95% CI 9.35 to 32.26). Neither association establishes a transmission pathway to patients. The authors recommended: "Dogs that visit health-care facilities should be prevented from licking patients", and also no treats from patients and no sitting on beds without a barrier.
Policies on raw feeding vary. In a US survey, only 5 of 27 therapy-animal organizations explicitly prohibited raw meat diets. Another 19 of the 24 organizations providing usable responses reported no such prohibition; three organizations did not answer the question. Not having a prohibition does not necessarily mean expressly permitting raw feeding (Linder et al., 2017). A practice paper from a long-standing hospital program cited the inconsistent rules as an example of missing standards (Barker & Gee, 2021).
In practice: Teams trained at our school do not feed raw meat to dogs that visit hospitals, keep up regular veterinary checks and fecal and parasite screening, and teach the dog a calm greeting without licking faces or hands. The dog is rewarded only from the handler's own treat pouch, never by patients, and the handler offers hand sanitizer to everyone before and after contact. This is a practice recommendation, not a study result.
7.4 Rules, and How Facilities Fall Short
US expert guidance from the Society for Healthcare Epidemiology of America (SHEA) addresses acute care hospitals and ambulatory settings; the evidence was too limited for formal grading (Murthy et al., 2015). For routine animal-assisted visitation programs it recommends dogs only, a minimum age of one year (ideally at least two), at least six months in the current home, preventing licking, hand hygiene before and after contact, and excluding dogs for at least a week after vomiting or diarrhea. Scratches and bites must be reported. Healthcare personnel should not feed treats to animals. A narrowly defined exception allows individual patients to offer handler-supplied, appropriate treats when this has substantial therapeutic benefit, subject to additional hygiene precautions. The guidance also excludes animals that have received raw or dehydrated-but-still-raw animal-origin foods, chews or treats in the preceding 90 days, with exceptions for high-pressure-pasteurized or gamma-irradiated products. For routine animal visits it identifies intensive care units, isolation rooms and neonatal areas, among others, as restricted locations. The later ICU projects discussed in this article therefore differ from this older guidance and require separate clinical risk assessments. In the hospital policies SHEA surveyed, exclusion criteria included isolation (60%), immunocompromise (30%), allergy (25%) and fear of animals (25%). SHEA guidance is a US expert recommendation, not a universally applicable law.
In a 2013–2014 US survey of 45 hospitals, 45 eldercare facilities and 27 therapy-animal organizations, every facility that allowed animals retrospectively fell short of at least one criterion in the SHEA guidance published in 2015 (Linder et al., 2017). That guidance had not yet been issued at the time of the survey; the comparison was made after the fact. A practice paper concluded that standardized policies "to minimize risk ... and protect therapy dog welfare are lacking" (Barker & Gee, 2021). Similar questions arise wherever dogs work with groups of people (what research shows about dogs in the classroom).
Protocols in the clinical studies show what stricter rules look like. The Essen program largely followed SHEA: children with neutrophils below 500/µL, within seven days of surgery, with uncoverable wounds, or with MRSA or multi-resistant gram-negative colonization or bacterial infection were excluded, hands were sanitized before and after, contact surfaces were disinfected, and the dog was screened for human pathogens and zoonoses (Steff et al., 2024). The Brazilian oncology program developed similar exclusion rules, including neutropenia, fever, isolation precautions, invasive devices and allergy, with the hospital infection commission (Silva & Osório, 2018).
7.5 Infections, Bites and Allergies: No Signal, but Rarely Measured
Several programs reported no rise in clinical infections, but their study designs and sample sizes cannot reliably rule out an increase. In the Florence pilot, 138 children took part in 20 dog-visiting sessions. Separately, the hospital infection committee compared hospital-wide infection figures after one year of weekly dog visits with those of the previous year and reported no increase. The paper did not provide detailed infection rates or confidence intervals; this was not a controlled demonstration of safety. Staff requested more information about safety (Caprilli & Messeri, 2006). In Essen, an uncontrolled observational program followed 60 children during a total of 100 dog visits. No statistically significant increase in infections or unplanned hospitalizations was reported during the observation period extending from two months before the first dog visit to two months after the last; no zoonoses were detected, and screening tests of the dog were negative (Steff et al., 2024). In Canberra, no new MRSA was found, and the two new VRE colonizations occurred in patients transferred without admission screening (Cook et al., 2025). The joint replacement trial recorded no surgical-site infections up to 12 months (Harper et al., 2015). None of these studies was designed or powered to detect a rare increase in infections.
For other harms, the evidence gap is larger. A literature review of hospital AAI programs found "substantial heterogeneity in infection control practices", that "Few data confirmed pathogen transmission between therapy animals and patients", and that no study up to 2020 had systematically measured "phobias, allergies, or injuries" (Dalton, Waite, et al., 2020). In the studies considered here, trials excluded patients with dog allergy or fear of dogs (Kelker et al., 2025; Steff et al., 2024), and those that reported harms found none (Calcaterra et al., 2015; López-Fernández et al., 2024; Cook et al., 2025). Only a few, such as the Seattle and Canberra studies, monitored adverse events in a prespecified way.
7.6 COVID-19 and the Restart of Programs
The pandemic stopped most programs. Of 20 US children's hospitals, 18 responded to a survey; all had offered animal-assisted activities before 2020, and 13 had resumed in-person visits by early 2022, most without group visits and with symptom-free, vaccinated, masked handlers with eye protection (Chubak et al., 2023). At the Virginia center, the prescribed protective equipment was worn for 100% of the 57 observed visits. Hand-hygiene requirements were met in 79.9% of the 1,016 recorded interactions (including 27 no-contact interactions for which sanitizer was not required), and 45 of 48 visits with documented duration (93.8%) lasted less than 120 minutes; visit length was missing for nine visits (Townsend et al., 2022).
8. The Dogs
8.1 What the Few Studies Measured
Most hospital trials did not measure the dogs at all, and the mixed-species review noted that animal welfare data were missing in most studies (Bert et al., 2016). A review of therapy dog welfare found that eight of twelve studies had fewer than ten dogs, with a median of 7.5, and that cortisol during work was mostly similar to non-working baseline values (Glenk & Foltin, 2021) (what animal-assisted interventions mean for the dog).
At the Mayo Clinic, 19 therapy dogs each worked five 20-minute sessions with outpatients with fibromyalgia, with both patient and dog free to interact or not (Clark, Martin, et al., 2020). Heart rate was significantly lower at the end of sessions than at the beginning. Right-ear tympanic temperature also decreased significantly (p = 0.0036), but left-ear temperature did not (p = 0.22). There were no significant pre-to-post differences in cortisol, oxytocin or the measured heart-rate-variability indices. As not all measurements were available for every dog at every session and no behavior data were collected, these results cannot establish comprehensive welfare outcomes. The dogs' behavior was not recorded, to protect the patients' privacy. In a pilot with nine new teams during their first three visits to the same institution, which lasted 47 minutes on average with about nine people per visit, dog cortisol did not differ across visits or time points; handlers' ratings of their dog's stress correlated with the dog's cortisol, and the most frequent behaviors were panting, lip licking and yawning, with leaning, turning away and shaking off also recorded (Clark, Smidt, et al., 2020).
The Pavia surgery program observed its single dog, an experienced seven-year-old Golden Retriever, on video during 20 post-operative sessions of 20 minutes (Palestrini et al., 2017). The dog panted for a mean 28.35% of session time and showed avoidance or withdrawal for 0.06%. Usable heart-rate data were available for only ten sessions and remained within the authors' cited normal reference range of 60 to 110 beats per minute; there were no comparison measurements outside work sessions. The authors observed no clear signs of stress or exhaustion under these conditions. Panting may also reflect ambient temperature or arousal, however, and findings from one dog cannot be generalized. Cortisol, heart rate and behavior each capture only part of what a dog experiences (what stress measures in dogs can and cannot show).
8.2 Session Length, Novelty and Contact
An earlier review concluded that the frequency and duration of sessions, the novelty of the environment, controllability, for example off-leash versus on-leash work, and the age and familiarity of the people a dog meets all modulate welfare indicators, while clear conclusions were lacking (Glenk, 2017). In the broader literature, transport and direct handling by recipients were associated with more stress behavior (Glenk & Foltin, 2021). Hospitals combine several of these factors, with many unfamiliar people and frequent touching (how dogs respond to different kinds of touch).
Real-world contacts last about one to six minutes per person, but a dog may meet many people in a row (Townsend et al., 2022). The Essen dog made 100 visits over four years between the ages of 7 and 11 (Steff et al., 2024). How often and how long a dog can work in a hospital without excessive strain has not been tested in the studies considered here. A review cited the recommendation that animals "should be closely monitored for signs of fatigue and given ample opportunity" to rest (Glenk, 2017).
8.3 Choice, Consent and the Handler as Advocate
A practice paper based on de-identified hospital cases argued that patient demand, the setting and the handler's own desire to help can lead handlers to miss stress signals, that humans often overlook subtle signals, and that dogs express "assent and dissent" that should be respected (Townsend & Gee, 2021). Another practice paper from a long-running hospital program describes a ladder of escalating stress signals, from yawning, nose licking and turning away to ears back, tucked tail and crouching, and finally stiffening, and names compassion fatigue in handlers as a risk (Barker & Gee, 2021) (what calming signals are and how to read them). Both are expert opinion, and their authors run the program they describe.
The studies also contain incidents on the dog's side. In the schizophrenia trial, one patient left "due to the risk of harm to the therapy dogs" (Calvo et al., 2016), and in the UK intensive care survey one site reported harm to an animal that ate a prohibited food item (Wright et al., 2025). A review argued that welfare research should also capture positive states, for example with behavioral observation and standardized questionnaires, not only the absence of stress (Miller et al., 2022). Controllability, including the option to leave, is among the factors a review linked to welfare indicators (Glenk, 2017) (why control and predictability reduce stress).
In practice: Teams trained at our school agree with the hospital in writing that the handler may interrupt or end a visit at any time for the dog's sake. They plan breaks in a quiet room before the dog needs one, keep visits within an agreed time limit, let the dog withdraw from contact without calling it back, and end the round when signals such as yawning, lip licking or turning away accumulate. This is a practice recommendation, not a study result.
8.4 Facility Dogs: Full-Time Work, Little Welfare Data
Among the studies considered here, no welfare study of full-time hospital facility dogs was found. The staff studies show what facility dogs do, but not how they fare: one Japanese hospital had employed two nurse–dog teams in succession since its program began in 2010 (Murata-Kobayashi et al., 2023), and facility-dog handlers described added burdens and responsibilities (Rodriguez et al., 2022). A dog that works every shift alongside its handler needs protected rest, the same attention to stress signals as a visiting dog, and a plan for reduced work and retirement as it ages.
9. Why the Evidence Stays Weak
9.1 Blinding and the Question of What the Dog Adds
During direct dog visits, blinding participants to the presence of the dog is practically impossible. Several trials stated that outcome assessors or research staff were not blinded (Calcaterra et al., 2015; Jennings et al., 2021; Chubak et al., 2024), or that blinding "was not possible" and could lead to "overestimation of effects" (Kelker et al., 2025). Most trials compared dog visits with usual care, so the effects of extra attention and novelty may be mistakenly attributed to the dog alone. Only a few used a human comparison: in the psychiatric trial, depression fell similarly with handler-only visits (Gee et al., 2026), in older inpatients handler-only visits did not differ significantly from usual care, while a direct advantage of the dog over the handler was not established either (Gee et al., 2024), and in the pediatric emergency trial both groups had child life support, but only one had an extra visitor (Kelker et al., 2025). A non-significant difference between a dog visit and another visit does not mean the two are equally effective; such trials were usually too small to show equivalence. A critical commentary called for designs that test the incremental effect of the animal (López-Cepero, 2020).
9.2 Designs, Sample Size and Follow-Up
Many studies had no control group, randomized days or shifts rather than individuals, or allocated by whether the dog was present (Sections 3 and 4). Samples were often small, down to 26 children in a trial stopped early (Chubak et al., 2024) and 22 completers (Calvo et al., 2016), and in some follow-up assessments an initially observed short-term advantage was no longer detectable (Kelker et al., 2025; Gee, Townsend, Friedmann, Barker, & Mueller, 2025). Within-group improvements are often presented next to absent between-group differences (Rodrigo-Claverol et al., 2026; Chubak et al., 2024).
9.3 Reporting, Statistics and Funding
A new reporting guideline for dog-assisted intervention trials lists 71 extension items to SPIRIT and CONSORT and names common problems: "lack of statistical power; large heterogeneity of outcome measures; an absence of manualised intervention protocols (including details relating to the animal partner ...) and well-designed control conditions"; trials "must consider the welfare and safety for the patient, dog, and therapist/handler" (Hall et al., 2026). Statistical reporting was not always consistent, for example a pooled estimate labeled as a mean difference across different scales (Zhang et al., 2021), which is why this article reports such results cautiously. Several trials were funded by organizations with an interest in human-animal interaction or by the pet and animal-health industry, as noted for each study above. Funding is not proof of bias, but readers should know it.
10. Practical Consequences for Dog Professionals
Dog visits can be offered to hospitals with a realistic promise: short-term relief of anxiety and distress is the most consistent finding, while effects on pain, depression and physiology are inconsistent, and longer-term benefits remain inadequately established (Correale et al., 2022; Lundqvist et al., 2017; Kelker et al., 2025). A 2023 review regarded animal-assisted interventions in intensive care as experimental in light of the limited effectiveness and safety evidence available at that time (Fiore et al., 2023). Patients who fear dogs or have a clinically significant dog allergy should not receive dog visits. Isolation areas are subject to the hospital's exclusion rules. For immunocompromised patients, the clinical team and infection prevention staff should assess the individual infection risk and suitability of a visit; not every degree of immunosuppression justifies an absolute ban (Murthy et al., 2015; Steff et al., 2024).
For hygiene, the strongest points are preventing licking, no treats from patients, no lying on beds without a barrier, hand hygiene before and after contact, no raw feeding and regular veterinary health checks for the dog (Lefebvre et al., 2009; Murthy et al., 2015; Chubak et al., 2024). For the dog, the reviews support attention to session length, novelty and controllability, the option to opt out, and observation of stress signals (Glenk, 2017; Glenk & Foltin, 2021; Townsend & Gee, 2021).
In practice: Before a team starts in a hospital, our school asks for a written agreement covering which wards and patients the dog may visit, contact persons in infection control, the maximum visit length, a quiet retreat room and how incidents are reported. Teams document each visit with date, duration, ward, number of contacts, the dog's behavior and any incident, so that the program can be evaluated and adjusted. This is a practice recommendation, not a study result.
11. Summary at a Glance
In children, dog visits reduced short-term anxiety and distress in most studies, but pain improved significantly in only two of five controlled studies, a small randomized pediatric oncology study found no statistically significant difference in children's immediately reported symptoms, and in a pediatric emergency RCT the anxiety advantage was no longer statistically significant at the later measurement, about two to two and a half hours after the start (Correale et al., 2022; Chubak et al., 2024; Kelker et al., 2025). Adult emergency trials reported less anxiety and small pain reductions without controlling for the handler (Kline et al., 2019; Carey et al., 2022), and in psychiatric inpatients depression fell similarly with handler-only visits (Gee et al., 2026).
Staff studies using varied designs – from short randomized comparisons to cross-sectional surveys and qualitative interviews – describe acceptance, possible short-term relief and extra burdens for facility-dog handlers (Acquadro Maran et al., 2022; Jensen et al., 2021; Rodriguez et al., 2022). Licking and treats from patients were associated with dogs acquiring pathogens, and in one small randomized trial, hand microbial levels after dog visits with sanitization met a prespecified non-inferiority criterion compared with usual care (Lefebvre et al., 2009; Chubak et al., 2024). Data on the dogs come from a few small studies (Clark, Martin, et al., 2020; Palestrini et al., 2017).
12. Limitations and Research Gaps
12.1 Adverse Events
In the studies covered by the 2020 review, bites, allergic reactions, falls and phobic reactions were not measured systematically (Dalton, Waite, et al., 2020), and only a few studies monitored adverse events in a prespecified way. No study was powered to detect differences in clinical infection rates (Chubak et al., 2024), and adequately powered, controlled ICU safety studies are still missing. Fiore et al. (2023) found no relevant safety outcomes in the studies available at that time. Later uncontrolled ICU studies did collect selected adverse-event and resistant-organism screening data (Cook et al., 2025), but cannot reliably exclude rare risks.
12.2 What the Dog Specifically Adds
Only a few trials considered here used a human-visitor control. In a psychiatric pilot trial, dog visits showed short-term advantages for some loneliness and anxiety measures, depending on the scale and assessment time, but not a consistently larger improvement in mood or any added benefit for depression compared with handler-only conversation (Gee, Townsend, Friedmann, Barker, Thakre, et al., 2025; Gee et al., 2026). In older inpatients, an advantage of the dog over the handler alone was also not statistically established (Gee et al., 2024).
12.3 Durability and Dose
Many acute-care studies measured changes only immediately after individual visits. In some studies, an initial short-term advantage was no longer statistically detectable at later assessments (Kelker et al., 2025; Gee, Townsend, Friedmann, Barker, & Mueller, 2025). These findings neither establish nor generally rule out longer-term effects. No study considered here compared visit lengths or frequencies.
12.4 The Dogs' Welfare
Dog-side data rest on small samples and mainly on cortisol and heart rate (Glenk & Foltin, 2021; Clark, Martin, et al., 2020; Palestrini et al., 2017). Among the studies considered here, none examined full-time facility dogs or cumulative load over years of hospital work.
12.5 Settings and Regions
Among the studies considered here, the German-speaking region is represented by an uncontrolled pediatric oncology study in Essen, a qualitative palliative care study in Düsseldorf and a German-led review (Steff et al., 2024; Schmitz et al., 2017; Fornefeld et al., 2025); no controlled trial from an acute hospital in Germany, Austria or Switzerland was found. The policy surveys come from the United States (Linder et al., 2017; Murthy et al., 2015).
13. Conclusion
Dogs in hospitals are not an adequately established treatment for every indication, but neither are they merely a pleasant extra. The most consistent finding is a short-term reduction in anxiety and distress, in children and adults, while effects on pain, depression and physiology are inconsistent and longer-term benefits remain inadequately established (Correale et al., 2022; Kelker et al., 2025; Gee, Townsend, Friedmann, Barker, & Mueller, 2025). How much of the effect comes from the dog rather than from a friendly visitor has rarely been tested (Gee et al., 2026).
For dog professionals, this means offering hospital visits honestly, following strict hygiene rules, especially no licking and no treats from patients, and protecting the dog with short visits, breaks, choice and an attentive handler. Better trials need human-visitor controls, blinded assessors, systematic recording of adverse events and outcomes for the dogs (Hall et al., 2026).
Key Insights (Takeaways)
In pediatric hospital studies, anxiety and distress decreased in most studies, but only two of five controlled studies showed a significant pain improvement (Correale et al., 2022).
A dog-only review across health care found at least one positive effect in 15 of 18 controlled studies, but no significant effect for most outcome measures (Lundqvist et al., 2017).
In a pediatric emergency RCT, a ten-minute dog visit added to child life care reduced anxiety more than child life care alone, but at the later measurement, about two to two and a half hours after the start, the difference was no longer statistically significant (Kelker et al., 2025).
In psychiatric inpatients, depression decreased similarly with dog-and-handler and handler-only visits, so what the dog specifically adds is still unclear (Gee et al., 2026).
Dogs that visited healthcare facilities acquired C. difficile more often than other AAI dogs, and licking patients and accepting treats from patients were associated with acquiring pathogens (Lefebvre et al., 2009).
In a small pediatric oncology trial, hand microbial load after dog visits with sanitization met the prespecified non-inferiority criterion compared with usual care (Chubak et al., 2024).
Welfare studies of therapy dogs have a median of 7.5 dogs, and no welfare study of full-time hospital facility dogs was found among the studies considered here (Glenk & Foltin, 2021).
References
Acquadro Maran, D., Capitanelli, I., Cortese, C. G., Ilesanmi, O. S., Gianino, M. M., & Chirico, F. (2022). Animal-assisted intervention and health care workers' psychological health: A systematic review of the literature. Animals, 12(3), 383. https://doi.org/10.3390/ani12030383
Barker, S. B., & Gee, N. R. (2021). Canine-assisted interventions in hospitals: Best practices for maximizing human and canine safety. Frontiers in Veterinary Science, 8, 615730. https://doi.org/10.3389/fvets.2021.615730
Baweja, J., Coe, J. B., Kamal, M., Noorloos, J., Saragosa, M., Nowrouzi-Kia, B., & Gohar, B. (2026). A qualitative inquiry to understand the impact of a facility dog on hospital workers' perceived organizational support. INQUIRY, 63, 00469580261417528. https://doi.org/10.1177/00469580261417528
Bert, F., Gualano, M. R., Camussi, E., Pieve, G., Voglino, G., & Siliquini, R. (2016). Animal assisted intervention: A systematic review of benefits and risks. European Journal of Integrative Medicine, 8(5), 695–706. https://doi.org/10.1016/j.eujim.2016.05.005
Boyle, S. F., Corrigan, V. K., Buechner-Maxwell, V., & Pierce, B. J. (2019). Evaluation of risk of zoonotic pathogen transmission in a university-based animal assisted intervention (AAI) program. Frontiers in Veterinary Science, 6, 167. https://doi.org/10.3389/fvets.2019.00167
Calcaterra, V., Veggiotti, P., Palestrini, C., De Giorgis, V., Raschetti, R., Tumminelli, M., Mencherini, S., Papotti, F., Klersy, C., Albertini, R., Ostuni, S., & Pelizzo, G. (2015). Post-operative benefits of animal-assisted therapy in pediatric surgery: A randomised study. PLOS ONE, 10(6), e0125813. https://doi.org/10.1371/journal.pone.0125813
Calvo, P., Fortuny, J. R., Guzmán, S., Macías, C., Bowen, J., García, M. L., Orejas, O., Molins, F., Tvarijonaviciute, A., Cerón, J. J., Bulbena, A., & Fatjó, J. (2016). Animal assisted therapy (AAT) program as a useful adjunct to conventional psychosocial rehabilitation for patients with schizophrenia: Results of a small-scale randomized controlled trial. Frontiers in Psychology, 7, 631. https://doi.org/10.3389/fpsyg.2016.00631
Caprilli, S., & Messeri, A. (2006). Animal-assisted activity at A. Meyer Children's Hospital: A pilot study. Evidence-Based Complementary and Alternative Medicine, 3(3), 379–383. https://doi.org/10.1093/ecam/nel029
Carey, B., Dell, C. A., Stempien, J., Tupper, S., Rohr, B., Carr, E., Cruz, M., Acoose, S., Butt, P., Broberg, L., Collard, L., Fele-Slaferek, L., Fornssler, C., Goodridge, D., Gunderson, J., McKenzie, H., Rubin, J., Shand, J., Smith, J., … Meier, S. (2022). Outcomes of a controlled trial with visiting therapy dog teams on pain in adults in an emergency department. PLOS ONE, 17(3), e0262599. https://doi.org/10.1371/journal.pone.0262599
Chubak, J., Adler, A., Bobb, J. F., Hawkes, R. J., Ziebell, R. A., Pocobelli, G., Ludman, E. J., & Zerr, D. M. (2024). A randomized controlled trial of animal-assisted activities for pediatric oncology patients: Psychosocial and microbial outcomes. Journal of Pediatric Health Care, 38(3), 354–364. https://doi.org/10.1016/j.pedhc.2023.09.010
Chubak, J., Pocobelli, G., Ziebell, R. A., Hawkes, R. J., Adler, A., Bobb, J. F., & Zerr, D. M. (2023). Effects of the COVID-19 pandemic on animal-assisted activities in pediatric hospitals. Journal of Pediatric Health Care, 37(2), 173–178. https://doi.org/10.1016/j.pedhc.2022.09.011
Clark, S. D., Martin, F., McGowan, R. T. S., Smidt, J. M., Anderson, R., Wang, L., Turpin, T., Langenfeld-McCoy, N., Bauer, B. A., & Mohabbat, A. B. (2020). Physiological state of therapy dogs during animal-assisted activities in an outpatient setting. Animals, 10(5), 819. https://doi.org/10.3390/ani10050819
Clark, S. D., Smidt, J. M., & Bauer, B. A. (2020). Therapy dogs' and handlers' behavior and salivary cortisol during initial visits in a complex medical institution: A pilot study. Frontiers in Veterinary Science, 7, 564201. https://doi.org/10.3389/fvets.2020.564201
Coakley, A. B., & Mahoney, E. K. (2009). Creating a therapeutic and healing environment with a pet therapy program. Complementary Therapies in Clinical Practice, 15(3), 141–146. https://doi.org/10.1016/j.ctcp.2009.05.004
Cook, K., Robertson, C., Gudivada, K., Mitchell, I., Nourse, M., Hosey, M. M., Paterson, C., & Rai, S. (2025). Pawsitive care: Canine-assisted intervention for anxiety in ICU patients and family members: A single-center, single-arm study. Critical Care Explorations, 7(5), e1258. https://doi.org/10.1097/cce.0000000000001258
Correale, C., Borgi, M., Collacchi, B., Falamesca, C., Gentile, S., Vigevano, F., Cappelletti, S., & Cirulli, F. (2022). Improving the emotional distress and the experience of hospitalization in children and adolescent patients through animal assisted interventions: A systematic review. Frontiers in Psychology, 13, 840107. https://doi.org/10.3389/fpsyg.2022.840107
Cowfer, B. A., Akard, T. F., & Gilmer, M. J. (2021). Animal-assisted interventions for children with advanced cancer: Child and parent perceptions. Palliative Medicine Reports, 2(1). https://doi.org/10.1089/pmr.2021.0039
Dalton, K. R., Campbell, P., Altekruse, W., Thorpe, R. J., Agnew, J., Ruble, K., Carroll, K. C., & Davis, M. F. (2022). A conceptual framework to address administrative and infection control barriers for animal-assisted intervention programs in healthcare facilities: Perspectives from a qualitative study. Infection Control & Hospital Epidemiology, 43(4), 531–533. https://doi.org/10.1017/ice.2021.24
Dalton, K. R., Rock, C., Carroll, K. C., & Davis, M. F. (2020). One Health in hospitals: How understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections. Antimicrobial Resistance & Infection Control, 9(1), 78. https://doi.org/10.1186/s13756-020-00737-2
Dalton, K. R., Ruble, K., Redding, L. E., Morris, D. O., Mueller, N. T., Thorpe, R. J., Agnew, J., Carroll, K. C., Planet, P. J., Rubenstein, R. C., Chen, A. R., Grice, E. A., & Davis, M. F. (2021). Microbial sharing between pediatric patients and therapy dogs during hospital animal-assisted intervention programs. Microorganisms, 9(5), 1054. https://doi.org/10.3390/microorganisms9051054
Dalton, K. R., Waite, K. B., Ruble, K., Carroll, K. C., DeLone, A., Frankenfield, P., Serpell, J. A., Thorpe, R. J., Morris, D. O., Agnew, J., Rubenstein, R. C., & Davis, M. F. (2020). Risks associated with animal-assisted intervention programs: A literature review. Complementary Therapies in Clinical Practice, 39, 101145. https://doi.org/10.1016/j.ctcp.2020.101145
Etingen, B., Martinez, R. N., Smith, B. M., Hogan, T. P., Miller, L., Saban, K. L., Irvin, D., Jankowski, B., & Weaver, F. M. (2020). Developing an animal-assisted support program for healthcare employees. BMC Health Services Research, 20(1), 714. https://doi.org/10.1186/s12913-020-05586-8
Fiore, M., Cortegiani, A., Friolo, G., Frigieri Covani, F., Cardia, L., Ferraro, F., & Alampi, D. (2023). Risks and benefits of animal-assisted interventions for critically ill patients admitted to intensive care units. Journal of Anesthesia, Analgesia and Critical Care, 3(1), 15. https://doi.org/10.1186/s44158-023-00100-y
Fornefeld, D., Zellin, U., Schmidt, P., & Fricke, O. (2025). The supporting role of dogs in the inpatient setting: A systematic review of the therapeutic effects of animal-assisted therapy with dogs for children and adolescents in an inpatient setting. European Child & Adolescent Psychiatry, 34(1), 3–17. https://doi.org/10.1007/s00787-023-02326-1
Gee, N. R., Townsend, L., Friedmann, E., Barker, S. B., & Mueller, M. K. (2024). A pilot randomized controlled trial to examine the impact of a therapy dog intervention on loneliness in hospitalized older adults. Innovation in Aging, 8(11), igae085. https://doi.org/10.1093/geroni/igae085
Gee, N. R., Townsend, L., Friedmann, E., Barker, S., & Mueller, M. (2025). A pilot randomized controlled trial to examine the impact of a therapy dog intervention on depression, mood, and anxiety in hospitalized older adults. Healthcare, 13(15), 1819. https://doi.org/10.3390/healthcare13151819
Gee, N. R., Townsend, L., Friedmann, E., Barker, S. B., Thakre, T. P., & Mueller, M. K. (2025). A pilot randomized controlled trial to examine the impact of a therapy dog intervention on loneliness in adult patients hospitalized in a psychiatric unit. Frontiers in Psychiatry, 16, 1582767. https://doi.org/10.3389/fpsyt.2025.1582767
Gee, N. R., Townsend, L., Friedmann, E., Barker, S. B., Thakre, T. P., & Mueller, M. K. (2026). A pilot randomized controlled trial examining the impact of therapy dog visitation on mood, anxiety, and depression in patients hospitalized for the treatment of mental illness. Healthcare, 14(10), 1420. https://doi.org/10.3390/healthcare14101420
Glenk, L. M. (2017). Current perspectives on therapy dog welfare in animal-assisted interventions. Animals, 7(2), 7. https://doi.org/10.3390/ani7020007
Glenk, L. M., & Foltin, S. (2021). Therapy dog welfare revisited: A review of the literature. Veterinary Sciences, 8(10), 226. https://doi.org/10.3390/vetsci8100226
Grissim, L., Shreeve, S., Keller, B. P., Robertson, M., Runyan, P., & Boles, J. (2025). Facility dog intervention and young children's anxiety during outpatient echocardiography. Cardiology in the Young, 35(10), 2024–2029. https://doi.org/10.1017/s1047951125109530
Guillen Guzmán, E., Sastre Rodríguez, L., Santamarina-Perez, P., Hermida Barros, L., García Giralt, M., Domenec Elizalde, E., Ristol Ubach, F., Romero Gonzalez, M., Pastor Yuste, Y., Diaz Téllez, C., Romero Cela, S., Real Gisbert, L., Salmeron Medina, M., Ballesteros-Urpi, A., & Morer Liñan, A. (2022). The benefits of dog-assisted therapy as complementary treatment in a children's mental health day hospital. Animals, 12(20), 2841. https://doi.org/10.3390/ani12202841
Hall, S. S., Shoesmith, E., Riga, E., Mills, D. S., Gibsone, S., McMillan, D., Wu, Q., Clarke, C., & Ratschen, E. (2026). Reporting of dog-assisted intervention trials: Extension of the SPIRIT 2025 and CONSORT 2025 statement. BMC Medical Research Methodology, 26(1), 113. https://doi.org/10.1186/s12874-026-02848-7
Harper, C. M., Dong, Y., Thornhill, T. S., Wright, J., Ready, J., Brick, G. W., & Dyer, G. (2015). Can therapy dogs improve pain and satisfaction after total joint arthroplasty? A randomized controlled trial. Clinical Orthopaedics and Related Research, 473(1), 372–379. https://doi.org/10.1007/s11999-014-3931-0
Hosey, M. M., Jaskulski, J., Wegener, S. T., Chlan, L. L., & Needham, D. M. (2018). Animal-assisted intervention in the ICU: A tool for humanization. Critical Care, 22(1), 22. https://doi.org/10.1186/s13054-018-1946-8
Jennings, M. L., Granger, D. A., Bryce, C. I., Twitchell, D., Yeakel, K., & Teaford, P. A. (2021). Effect of animal assisted interactions on activity and stress response in children in acute care settings. Comprehensive Psychoneuroendocrinology, 8, 100076. https://doi.org/10.1016/j.cpnec.2021.100076
Jensen, C. L., Bibbo, J., Rodriguez, K. E., & O'Haire, M. E. (2021). The effects of facility dogs on burnout, job-related well-being, and mental health in paediatric hospital professionals. Journal of Clinical Nursing, 30(9–10), 1429–1441. https://doi.org/10.1111/jocn.15694
Kelker, H. P., Siddiqui, H. K., Beck, A. M., & Kline, J. A. (2025). Therapy dogs for anxiety in children in the emergency department: A randomized clinical trial. JAMA Network Open, 8(3), e250636. https://doi.org/10.1001/jamanetworkopen.2025.0636
Kline, J. A., Fisher, M. A., Pettit, K. L., Linville, C. T., & Beck, A. M. (2019). Controlled clinical trial of canine therapy versus usual care to reduce patient anxiety in the emergency department. PLOS ONE, 14(1), e0209232. https://doi.org/10.1371/journal.pone.0209232
Kubanick, V., & Scharfman, J. (2025). Nurses' best friend? The lived experiences of nurses who utilized dog therapy in the workplace. Nursing Reports, 15(7), 246. https://doi.org/10.3390/nursrep15070246
Lefebvre, S. L., Arroyo, L. G., & Weese, J. S. (2006). Epidemic Clostridium difficile strain in hospital visitation dog. Emerging Infectious Diseases, 12(6), 1036–1037. https://doi.org/10.3201/eid1206.060115
Lefebvre, S. L., Reid-Smith, R. J., Waltner-Toews, D., & Weese, J. S. (2009). Incidence of acquisition of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and other health-care–associated pathogens by dogs that participate in animal-assisted interventions. Journal of the American Veterinary Medical Association, 234(11), 1404–1417. https://doi.org/10.2460/javma.234.11.1404
Linder, D. E., Siebens, H. C., Mueller, M. K., Gibbs, D. M., & Freeman, L. M. (2017). Animal-assisted interventions: A national survey of health and safety policies in hospitals, eldercare facilities, and therapy animal organizations. American Journal of Infection Control, 45(8), 883–887. https://doi.org/10.1016/j.ajic.2017.04.287
López-Cepero, J. (2020). Current status of animal-assisted interventions in scientific literature: A critical comment on their internal validity. Animals, 10(6), 985. https://doi.org/10.3390/ani10060985
López-Fernández, E., Palacios-Cuesta, A., Rodríguez-Martínez, A., Olmedilla-Jodar, M., Fernández-Andrade, R., Mediavilla-Fernández, R., Sánchez-Díaz, J. I., & Máximo-Bocanegra, N. (2024). Implementation feasibility of animal-assisted therapy in a pediatric intensive care unit: Effectiveness on reduction of pain, fear, and anxiety. European Journal of Pediatrics, 183(2), 843–851. https://doi.org/10.1007/s00431-023-05284-7
Lundqvist, M., Carlsson, P., Sjödahl, R., Theodorsson, E., & Levin, L.-Å. (2017). Patient benefit of dog-assisted interventions in health care: A systematic review. BMC Complementary and Alternative Medicine, 17(1), 358. https://doi.org/10.1186/s12906-017-1844-7
Machová, K., Procházková, R., Eretová, P., Svobodová, I., & Kotík, I. (2019). Effect of animal-assisted therapy on patients in the department of long-term care: A pilot study. International Journal of Environmental Research and Public Health, 16(8), 1362. https://doi.org/10.3390/ijerph16081362
Machová, K., Součková, M., Procházková, R., Vaníčková, Z., & Mezian, K. (2019). Canine-assisted therapy improves well-being in nurses. International Journal of Environmental Research and Public Health, 16(19), 3670. https://doi.org/10.3390/ijerph16193670
Miller, S. L., Serpell, J. A., Dalton, K. R., Waite, K. B., Morris, D. O., Redding, L. E., Dreschel, N. A., & Davis, M. F. (2022). The importance of evaluating positive welfare characteristics and temperament in working therapy dogs. Frontiers in Veterinary Science, 9, 844252. https://doi.org/10.3389/fvets.2022.844252
Murata-Kobayashi, N., Suzuki, K., Morita, Y., Minobe, H., Mizumoto, A., & Seto, S. (2023). Exploring the benefits of full-time hospital facility dogs working with nurse handlers in a children's hospital. PLOS ONE, 18(5), e0285768. https://doi.org/10.1371/journal.pone.0285768
Murthy, R., Bearman, G., Brown, S., Bryant, K., Chinn, R., Hewlett, A., George, B. G., Goldstein, E. J. C., Holzmann-Pazgal, G., Rupp, M. E., Wiemken, T., Weese, J. S., & Weber, D. J. (2015). Animals in healthcare facilities: Recommendations to minimize potential risks. Infection Control & Hospital Epidemiology, 36(5), 495–516. https://doi.org/10.1017/ice.2015.15
Palestrini, C., Calcaterra, V., Cannas, S., Talamonti, Z., Papotti, F., Buttram, D., & Pelizzo, G. (2017). Stress level evaluation in a dog during animal-assisted therapy in pediatric surgery. Journal of Veterinary Behavior, 17, 44–49. https://doi.org/10.1016/j.jveb.2016.09.003
Reddekopp, J., Dell, C. A., Rohr, B., Fornssler, B., Gibson, M., Carey, B., & Stempien, J. (2020). Patient opinion of visiting therapy dogs in a hospital emergency department. International Journal of Environmental Research and Public Health, 17(8), 2968. https://doi.org/10.3390/ijerph17082968
Rodrigo-Claverol, M., Manuel-Canals, M., Lobato-Rincón, L. L., Roman-Casenave, M., Rodríguez-Criado, N., Rodrigo-Claverol, E., Miró-Bernaus, Y., Musull-Dulcet, E., González-García, I., & Pifarre, J. (2026). Effectiveness of animal-assisted therapy in adolescent psychiatric inpatients: A multicenter clinical trial. BMC Complementary Medicine and Therapies, 26(1), 199. https://doi.org/10.1186/s12906-026-05385-4
Rodriguez, K. E., Bibbo, J., & O'Haire, M. E. (2022). Perspectives on facility dogs from pediatric hospital personnel: A qualitative content analysis of patient, family, and staff outcomes. Complementary Therapies in Clinical Practice, 46, 101534. https://doi.org/10.1016/j.ctcp.2022.101534
Rodriguez, K. E., Herzog, H., & Gee, N. R. (2021). Variability in human-animal interaction research. Frontiers in Veterinary Science, 7, 619600. https://doi.org/10.3389/fvets.2020.619600
Santaniello, A., Dicé, F., Claudia Carratú, R., Amato, A., Fioretti, A., & Menna, L. F. (2020). Methodological and terminological issues in animal-assisted interventions: An umbrella review of systematic reviews. Animals, 10(5), 759. https://doi.org/10.3390/ani10050759
Schmitz, A., Beermann, M., MacKenzie, C. R., Fetz, K., & Schulz-Quach, C. (2017). Animal-assisted therapy at a University Centre for Palliative Medicine – a qualitative content analysis of patient records. BMC Palliative Care, 16(1), 50. https://doi.org/10.1186/s12904-017-0230-z
Shoesmith, E., Hall, S., Sowden, A., Stevens, H., Pervin, J., Riga, J., McMillan, D., Mills, D., Clarke, C., Wu, Q., Gibsone, S., & Ratschen, E. (2026). Dog-assisted interventions for children and adults with mental health or neurodevelopmental conditions: Systematic review. The British Journal of Psychiatry, 228(2), 150–163. https://doi.org/10.1192/bjp.2025.8
Sikstrom, L., Meyer, T., Katz, E., Choi, M.-M., Darragh, M., Cutler-Palma, A., Conforti, T., Kalocsai, C., & Soklaridis, S. (2020). Increasing participation in research with therapy dogs: A qualitative study at a large urban mental health and addiction hospital. PLOS ONE, 15(8), e0238096. https://doi.org/10.1371/journal.pone.0238096
Silva, N. B., & Osório, F. L. (2018). Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients. PLOS ONE, 13(4), e0194731. https://doi.org/10.1371/journal.pone.0194731
Spikestein, A., Musante, J., Huang, H.-H., Stojanowski, M., Rode, D., Pillai, P., & Crouch, G. D. (2024). Impact of facility dog and certified child life specialist dyad on children's pain and anxiety during needlestick procedures in a pediatric hematology oncology clinic setting. Journal of Pediatric Hematology/Oncology, 46(1), 51–56. https://doi.org/10.1097/mph.0000000000002785
Steff, K., Grasemann, M., Ostermann, K., Goretzki, S. C., Rath, P.-M., Reinhardt, D., & Schündeln, M. M. (2024). Feasibility, efficacy, and safety of animal-assisted activities with visiting dogs in inpatient pediatric oncology. World Journal of Pediatrics, 20(9), 915–924. https://doi.org/10.1007/s12519-024-00829-8
Townsend, L., & Gee, N. R. (2021). Recognizing and mitigating canine stress during animal assisted interventions. Veterinary Sciences, 8(11), 254. https://doi.org/10.3390/vetsci8110254
Townsend, L., Gee, N. R., Friedmann, E., Mueller, M. K., Thakre, T. P., & Barker, S. B. (2026). Feasibility of recruiting psychiatrically hospitalized adults for a randomized controlled trial of an animal-assisted intervention. Healthcare, 14(2), 154. https://doi.org/10.3390/healthcare14020154
Townsend, L., Heatwole, J. K., & Gee, N. R. (2022). Reactivation of a hospital-based therapy dog visitation program during the COVID-19 pandemic. Animals, 12(14), 1842. https://doi.org/10.3390/ani12141842
Wright, S., McAree, H., Hosey, M., Tantam, K., & Connolly, B. (2025). Animal-assisted intervention services across UK intensive care units: A national service evaluation. Journal of the Intensive Care Society, 26(1), 68–79. https://doi.org/10.1177/17511437241301000
Zhang, Y., Yan, F., Li, S., Wang, Y., & Ma, Y. (2021). Effectiveness of animal-assisted therapy on pain in children: A systematic review and meta-analysis. International Journal of Nursing Sciences, 8(1), 30–37. https://doi.org/10.1016/j.ijnss.2020.12.009